Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$8.8 - $16.2 $8.12 Million - $14.9 Million
-922,371 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$12.5 - $52.0 $7.77 Million - $32.3 Million
621,847 Added 206.92%
922,371 $304,000
Q4 2021

Jan 31, 2022

BUY
$46.5 - $104.0 $12.3 Million - $27.5 Million
264,770 Added 740.53%
300,524 $279,000
Q3 2021

Nov 04, 2021

BUY
$80.5 - $175.0 $2.88 Million - $6.26 Million
35,754 New
35,754 $74,000

About Enveric Biosciences, Inc.


  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $665K
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Advisor Shares Investments LLC Portfolio

Follow Advisor Shares Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Shares Investments LLC with notifications on news.